Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation
The biological characteristics of early transmitted/founder (T/F) variants are crucial factors for viral transmission and constitute key determinants for the development of better therapeutics and vaccine strategies. The present study aimed to generate T/F viruses and to characterize their biologica...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/12/1854 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850035877067096064 |
|---|---|
| author | Aanand Sonawane Deepak Selvam Ling Yue Manohar Nesakumar Sandhya Vivekanandan Manickam Ashokkumar Eric Hunter Luke Elizabeth Hanna |
| author_facet | Aanand Sonawane Deepak Selvam Ling Yue Manohar Nesakumar Sandhya Vivekanandan Manickam Ashokkumar Eric Hunter Luke Elizabeth Hanna |
| author_sort | Aanand Sonawane |
| collection | DOAJ |
| description | The biological characteristics of early transmitted/founder (T/F) variants are crucial factors for viral transmission and constitute key determinants for the development of better therapeutics and vaccine strategies. The present study aimed to generate T/F viruses and to characterize their biological properties. For this purpose, we constructed 18 full-length infectious molecular clones (IMCs) of HIV from recently infected infants. All the clones were characterized genotypically through whole genome sequencing and phenotypically for infectivity, replication kinetics, co-receptor usage, as well as their susceptibility to neutralizing antibodies and entry inhibitors using standard virological assays. Genotypic analysis revealed that all the T/F clones were of non-recombinant subtype C, but some of them harboured the Y181C drug resistance mutation associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of antiretroviral drugs. In vitro studies showed that while all the IMCs were capable of replicating in PBMCs and utilized the CCR5 co-receptor for cellular entry, the drug-resistant variants had significantly lower replicative capacity and per particle infectivity than the drug-sensitive viruses. Both exhibited similar sensitivities to a standard panel of broadly neutralizing monoclonal antibodies and viral entry inhibitors. These findings suggest that despite their diminished replicative fitness, the drug-resistant T/F variants retain transmission fitness and remain susceptible to neutralizing antibody-based interventions and viral entry inhibitors. |
| format | Article |
| id | doaj-art-0ef27f96ed64461c82371b270cb2382c |
| institution | DOAJ |
| issn | 1999-4915 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Viruses |
| spelling | doaj-art-0ef27f96ed64461c82371b270cb2382c2025-08-20T02:57:21ZengMDPI AGViruses1999-49152024-11-011612185410.3390/v16121854Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated MutationAanand Sonawane0Deepak Selvam1Ling Yue2Manohar Nesakumar3Sandhya Vivekanandan4Manickam Ashokkumar5Eric Hunter6Luke Elizabeth Hanna7Department of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, IndiaDepartment of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, IndiaDepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USADepartment of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, IndiaDepartment of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, IndiaDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hil, NC 27599, USADepartment of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USADepartment of Virology & Biotechnology, ICMR-National Institute for Research in Tuberculosis, Chennai 600031, IndiaThe biological characteristics of early transmitted/founder (T/F) variants are crucial factors for viral transmission and constitute key determinants for the development of better therapeutics and vaccine strategies. The present study aimed to generate T/F viruses and to characterize their biological properties. For this purpose, we constructed 18 full-length infectious molecular clones (IMCs) of HIV from recently infected infants. All the clones were characterized genotypically through whole genome sequencing and phenotypically for infectivity, replication kinetics, co-receptor usage, as well as their susceptibility to neutralizing antibodies and entry inhibitors using standard virological assays. Genotypic analysis revealed that all the T/F clones were of non-recombinant subtype C, but some of them harboured the Y181C drug resistance mutation associated with resistance to the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of antiretroviral drugs. In vitro studies showed that while all the IMCs were capable of replicating in PBMCs and utilized the CCR5 co-receptor for cellular entry, the drug-resistant variants had significantly lower replicative capacity and per particle infectivity than the drug-sensitive viruses. Both exhibited similar sensitivities to a standard panel of broadly neutralizing monoclonal antibodies and viral entry inhibitors. These findings suggest that despite their diminished replicative fitness, the drug-resistant T/F variants retain transmission fitness and remain susceptible to neutralizing antibody-based interventions and viral entry inhibitors.https://www.mdpi.com/1999-4915/16/12/1854HIVtransmitted/founder virusinfectious molecular clonesNNRTI resistance |
| spellingShingle | Aanand Sonawane Deepak Selvam Ling Yue Manohar Nesakumar Sandhya Vivekanandan Manickam Ashokkumar Eric Hunter Luke Elizabeth Hanna Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation Viruses HIV transmitted/founder virus infectious molecular clones NNRTI resistance |
| title | Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation |
| title_full | Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation |
| title_fullStr | Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation |
| title_full_unstemmed | Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation |
| title_short | Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation |
| title_sort | virulence and replicative fitness of hiv 1 transmitted founder t f viruses harbouring drug resistance associated mutation |
| topic | HIV transmitted/founder virus infectious molecular clones NNRTI resistance |
| url | https://www.mdpi.com/1999-4915/16/12/1854 |
| work_keys_str_mv | AT aanandsonawane virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT deepakselvam virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT lingyue virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT manoharnesakumar virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT sandhyavivekanandan virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT manickamashokkumar virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT erichunter virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation AT lukeelizabethhanna virulenceandreplicativefitnessofhiv1transmittedfoundertfvirusesharbouringdrugresistanceassociatedmutation |